European drugs regulator recommends AstraZeneca's COVID drug | Reuters
The European Medicines Agency on Thursday authorised the use of AstraZeneca Plc's antibody drug for preventing COVID-19 infections in adults and adolescents over 12 years of age.
EMA lässt AstraZenecas Evusheld ab dem Alter von 12 Jahren zu
Zuletzt aktualisiert:
